EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Tilray Brands's Enterprise Value is €533.2 Mil.
Tilray Brands's Free Cash Flow for the trailing twelve months (TTM) ended in Feb. 2026 was €-63.7 Mil. Therefore, Tilray Brands's EV-to-FCF for today is -8.37.
The historical rank and industry rank for Tilray Brands's EV-to-FCF or its related term are showing as below:
WBO:TLR2'
s EV-to-FCF Range Over the Past 10 Years
Min: -151 Med: -14.1 Max: 134.76
Current: -8.19
During the past 13 years, the highest EV-to-FCF of Tilray Brands was 134.76. The lowest was -151.00. And the median was -14.10.
WBO:TLR2's EV-to-FCF is ranked worse than 100% of 562
companies
in the Drug Manufacturers industry
Industry Median: 20.11
vs WBO:TLR2: -8.19
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Tilray Brands's PE Ratio (TTM) for today is calculated as:
Tilray Brands's share price for today is €3.92.
Tilray Brands's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-12.089.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Tilray Brands EV-to-FCF Related Terms
Tilray Brands EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Tilray Brands's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:TLR2 vs IRWD, BIOA, ESPR: EV-to-FCF Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Tilray Brands's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tilray Brands EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Tilray Brands's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Tilray Brands's EV-to-FCF falls into.
Tilray Brands's current Enterprise Value is €533.2 Mil.
Tilray Brands's Free Cash Flow for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-63.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tilray Brands (WBO:TLR2) has a EV-to-FCF of -8.37 as of Jun. 26, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Tilray Brands and its competitors. According to the industry distribution chart, Tilray Brands ranks #999999 out of 562 companies in the Drug Manufacturers industry.
Is Tilray Brands' EV-to-FCF too high?
Tilray Brands' current EV-to-FCF is -8.37. Based on the distribution chart, Tilray Brands ranks #999999 out of 562 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Tilray Brands has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Tilray Brands' EV-to-FCF compare to IRWD and BIOA?
According to the Drug Manufacturers industry distribution chart, Tilray Brands ranks #999999 out of 562 companies for EV-to-FCF. This places Tilray Brands in the lower half of its industry. The industry median EV-to-FCF is 20.11. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.11, based on 562 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Tilray Brands and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tilray Brands's current EV-to-FCF is -8.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tilray Brands stock overvalued right now?
Based on GuruFocus' analysis, Tilray Brands (WBO:TLR2) is currently considered Possible Value Trap. The stock's GF Value™ is €10.82, compared to a current price of €3.92 — trading 63.8% below its estimated fair value. The current EV-to-FCF is -8.37. Tilray Brands' overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Tilray Brands (WBO:TLR2), the current EV-to-FCF is -8.37 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tilray Brands (WBO:TLR2) Overvalued in 2026?
Based on GuruFocus' analysis, Tilray Brands stock appears to be undervalued.
The current stock price of €3.92 is trading 63.8% below its estimated GF Value™ of €10.82.
GuruFocus considers Tilray Brands to be Possible Value Trap.
Key valuation signals for WBO:TLR2:
EV-to-FCF: -8.37
GF Value™: €10.82 vs. price of €3.92 (63.8% below fair value)
No single metric tells the full story. See the WBO:TLR2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
55GF Score
Get the complete analysis for WBO:TLR2
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:TLR2 has been successfully added to your 
